In vitro studies indicated that PPARβ/δ-ANGPTL4 pathway is involved in the regulation of tumor cell invasion and that its pharmacological manipulation by PPARβ/δ strongly inhibits the serum- and transforming growth factor β (TGFβ)-induced invasion of MDA-MB-231 human breast cancer cells [140]. The gene discussed is ANGPTL4; the disease is breast cancer.